Skip to main content
    N

    NRC Health (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $25.89
    -0.45 (-1.69%)

    Market Cap: $558.76M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    NRC Health (NRC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    NRC Health (NRC) has a market cap of $558.76M and an enterprise value of $658.04M. Its return on invested capital of 11.01% compares with a 1.43% median across 8 similar companies.

    Total Valuation

    Enterprise value is 17.77% above the market cap, as debt exceeds cash.

    Market Cap$558.76M
    Enterprise Value$658.04M
    Latest price (Nov 17, 2026)$25.89

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 29, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateOct 27, 2026
    Next Ex-Dividend DateDec 29, 2026
    Next Payment DateJan 8, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.29% in the quarter ended Sep 30, 2026 and shrank 4.30% a year over 2 years.

    Shares Outstanding21.72M
    Shares Change (YoY)-1.83%
    Shares Change (QoQ)-1.29%
    Share Count Growth (2Y CAGR)-4.30%

    Valuation Ratios

    The price to sales ratio is 3.9x. Its year-end P/E ranged from 16.9x to 52.3x from 2016 to 2025.

    P/E Ratio34.8x
    P/S Ratio3.9x
    Forward P/S3.8x
    P/FCF Ratio30.5x
    P/OCF Ratio23.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 27.0x EBITDA and 35.9x free cash flow.

    EV / Earnings102.2x
    EV / Sales4.6x
    EV / EBITDA27.0x
    EV / EBIT41.4x
    EV / FCF35.9x

    Price Statistics

    The stock is up 74.35% over 52 weeks and trades 16.20% above its 50-day average.

    Beta (1Y)0.80
    52-Week Change+74.35%
    1-Month Change+26.45%
    3-Month Change+18.73%
    6-Month Change+40.25%
    5-Year Change-44.97%
    10-Year Change+55.24%
    Total Return (1Y)+78.66%
    Total Return (3Y CAGR)-12.24%
    Total Return (5Y CAGR)-7.79%
    Return vs SPY (1Y)+53.88%
    Max Drawdown (1Y)-46.49%
    Max Drawdown (3Y)-75.07%
    Sharpe Ratio (1Y)0.86
    Correlation with SPY (1Y)0.19
    50-Day Average$22.28
    200-Day Average$19.29
    52-Week Range$11.45 to $27.60
    RSI (14 Days)61.8
    Average Volume (20 Days)118.90K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.64x current liabilities.

    Current Ratio0.64x
    Quick Ratio0.64x
    Debt / EBITDA4.20x
    Debt / FCF5.58x
    Interest Coverage2.90x

    Returns and Efficiency

    Return on invested capital is 11.01% over the last 12 months, against a 5-year average of 29.90%.

    Return on Assets (ROA)4.63%
    Return on Invested Capital (ROIC)11.01%
    Return on Capital Employed (ROCE)16.31%
    ROE (5Y Average)62.69%
    ROA (5Y Average)20.15%
    ROIC (5Y Average)29.90%
    Asset Turnover1.05x
    Receivables Turnover11.66x

    Taxes

    Income tax took 38.74% of pretax income over the last 12 months.

    Income Tax (TTM)$4.07M
    Effective Tax Rate38.74%

    Scores

    NRC has an Altman Z-Score of 3.32, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.32
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $143.79M over the last 12 months is up 3.37% from the 12 months before.

    Revenue$143.79M
    Revenue Growth (YoY)+3.37%
    Gross Profit$143.79M
    Operating Income$15.91M
    Pretax Income$10.51M
    Net Income$6.44M
    EBITDA$24.49M
    EBIT$15.88M
    Reported EPS (TTM)$0.74

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$3.63M
    Total Debt$102.90M
    Net Debt$99.27M
    Net Debt Per Share$4.57
    Working Capital-$15.13M
    Shareholder Equity-$9.12M
    Tangible Book Value-$77.31M
    Total Assets$139.21M
    Total Liabilities$148.34M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $5.32M of capital spending, operating cash flow left $18.45M of free cash flow.

    Operating Cash Flow$23.77M
    Capital Expenditures$5.32M
    Free Cash Flow$18.45M
    FCF Per Share$0.87
    Depreciation and Amortization$8.61M
    Dividends Paid$13.47M
    Share Repurchases$25.56M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 11.06%, against a 5-year average of 26.54%.

    Gross Margin100.00%
    Operating Margin11.06%
    Pretax Margin7.31%
    Net Margin4.48%
    EBITDA Margin17.03%
    EBIT Margin11.04%
    FCF Margin12.83%
    Operating Margin (5Y Average)26.54%
    Net Margin (5Y Average)18.58%

    Growth

    Revenue fell 3.22% a year over 3 years, and EPS 26.47% a year.

    Revenue Growth (3Y CAGR)-3.22%
    Revenue Growth (5Y CAGR)+0.61%
    EPS Growth (3Y CAGR)-26.47%
    EPS Growth (5Y CAGR)-19.03%
    FCF Growth (3Y CAGR)-15.86%
    FCF Growth (5Y CAGR)-15.55%
    Operating Income Growth (3Y CAGR)-21.41%
    Book Value Per Share Growth (2Y CAGR)-43.28%

    Revenue and profit by year

    Dividends and Yields

    NRC pays out 58.50% of earnings as dividends.

    Dividend Per Share (Annual)$0.64
    Dividend Yield2.47%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-14.77%
    Dividend Growth (5Y CAGR)+19.88%
    Payout Ratio58.50%
    FCF Payout Ratio73.03%
    Earnings Yield2.87%
    FCF Yield3.28%
    Buyback Yield4.55%
    Shareholder Yield6.94%

    Full dividend history

    Peer Position

    Against 7 similar companies, NRC has the 4th highest P/E.

    P/E Ratio34.8x vs 16.9x median
    P/S Ratio3.9x vs 2.5x median
    ROIC11.01% vs 1.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)+3.37% vs +11.38% median
    Dividend Yield2.47% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.22% and EPS growth at 44.91% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.22%
    EPS Growth Forecast (2Y CAGR)+44.91%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NRC

    What is NRC's market cap?

    NRC Health has a market cap of $558.76M. Its enterprise value, which adds debt and subtracts cash, is $658.04M.

    What is NRC's P/E ratio?

    NRC Health has a trailing P/E ratio of 34.8x.

    How many shares of NRC are outstanding?

    NRC Health has 21.72M shares outstanding. The count is down 1.83% from a year earlier.

    Does NRC pay a dividend?

    Yes. NRC Health pays $0.64 a share a year, a dividend yield of 2.47%.

    How much debt does NRC have?

    NRC Health has $102.90M of total debt and $3.63M of cash and equivalents, a net debt position of $99.27M.